Find AI stocks under $5 with potential for growth

``` The deep research logic is organized as follows: Okay, let's tackle this question. The user is asking for AI stocks under $5 with potential for growth. First, I need to check the references provided. Looking at the references, there are a few queries related to AI stocks under $5. Specifically, Query 1 and Query 7 both mention AI stocks with closing prices under $5, high EPS YoY growth, and a P/E ratio under 15. The results from these queries show Amesite Inc. (AMST) as the only stock meeting those criteria. Amesite's last price is $3.22, which is under $5. The diluted EPS YoY growth is 71.43%, which is quite high. However, the diluted EPS is negative at -$0.16, and the P/E ratio is -3.8, which is negative because the EPS is negative. That's a bit concerning, but the high growth rate might indicate potential. I should also consider the recent news about Amesite. There are several articles (Numbers 23-26) mentioning a 63% revenue growth for their NurseMagic platform after launching an Enterprise subscription model. The stock surged around 100% in premarket trading, which shows strong market reaction. This indicates that the company is making progress in their AI applications, particularly in the healthcare sector. However, there's also information about C3.ai (AI) facing securities fraud lawsuits (References 2,4,5,16,21,30). While C3.ai's stock price is higher than $5, the legal issues might affect the broader AI sector sentiment. But since the user is specifically asking for under $5, C3.ai isn't relevant here. Another point is the market cap. Query 32 shows Amesite has a market cap of $14.72 million and an average trading volume of 4.28 million shares. This is quite low, indicating it's a micro-cap stock, which comes with higher risk but also potential for high growth. The user's profile mentions interest in the NASDAQ Composite, which is tech-heavy. Amesite is listed on NASDAQ, so that aligns with the user's preference. I need to structure the answer with a conclusion first, then detailed analysis. The conclusion should highlight Amesite as the primary candidate. The analysis should cover the stock's financials, recent performance, market context, and risks. Also, include the visualization as per the query. Make sure to cite the references correctly. For example, the stock data from Query 1 and 7, the revenue growth from References 23-26, and the market cap from Query 32. Also, check if there are any other AI stocks under $5. From the provided references, only Amesite fits. So, the answer should focus on that. Potential risks include the negative EPS, high volatility, and the company's small size. But the high growth rate and recent product success might offset these risks. Finally, present the information in a clear table and include the visualization as specified. ``` ### Conclusion 🚀 **Amesite Inc. (AMST)** stands out as the sole AI stock under $5 with high growth potential, driven by its recent 71.43% YoY EPS growth and strategic AI advancements in healthcare automation. However, caution is warranted due to its negative EPS and micro-cap volatility. --- ### Detailed Analysis 📊 #### **1. Financial Profile** | Metric | Value | Implication | |----------------------------|----------------|------------------------------------------------------------------------------| | **Price** | $3.22 | Affordable entry point for high-growth tech stocks. | | **EPS YoY Growth** | 71.43% | Exceptional growth despite negative EPS (-$0.16) . | | **Market Cap** | $14.72M | Micro-cap status with high upside potential but elevated risk. | | **Avg. Trading Volume** | 4.28M shares | Liquidity supports active trading, though volatility is likely. | #### **2. Recent Catalysts** - **Revenue Surge**: Amesite reported **63% YoY revenue growth** for its NurseMagic platform , driven by AI-powered healthcare automation. - **Product Innovation**: Launched an AI-driven automated form-fill solution for government documentation , enhancing its competitive edge in post-acute care. - **Stock Reaction**: Shares surged **100%+** in premarket trading after the revenue update , reflecting strong market confidence. #### **3. Risks & Context** - **Negative EPS**: Despite high growth, the company remains unprofitable (-$0.16 EPS) , raising concerns about cash burn and sustainability. - **Micro-Cap Volatility**: With a $14.72M market cap , Amesite is highly sensitive to market swings and liquidity risks. - **Competition**: The AI sector is crowded, with giants like Nvidia (NVDA) and C3.ai (AI) dominating headlines . #### **4. Market Outlook** - **AI Growth**: The global AI market is projected to reach **$1.01T by 2031** (CAGR: 26.6%) , with healthcare automation as a key growth driver. - **Niche Focus**: Amesite’s focus on post-acute care (8% CAGR) offers a niche opportunity, though it limits diversification. --- ### Final Takeaway 🎯 **Amesite (AMST)** is a high-risk, high-reward play in the AI space, ideal for tech-savvy investors with a tolerance for volatility. While its recent product success and growth metrics are promising, the lack of profitability and micro-cap status require careful monitoring. Theme is AI; Closing Price < $5; EPS YoY Growth Rate > 10%; P/E Ratio < 15 |code|stock code|stock name|Last Price|Last Change|Theme|Inclusion Reason[20250918]|Closing Price[20250918]|Diluted Eps Yoy Growth[20250918]|Diluted EPS[20250918]|Report End Date[20250918]|Fiscal Date[20250918]|Report Period[20250918]|P/E(TTM)[20250918]|market_code| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |AMST|AMST.O|Amesite|3.22|2.547771|||3.24|71.42857142857143|-0.16|20250331|20250930|2025Q3|-3.800693|186|